UBIAD1 Antibody Summary
| Immunogen |
A synthetic peptide made to residues 32-45 [PEQDRLPQRSWRQK] of the 37 kDa human TERE1 protein.
|
| Localization |
Cell Membrane; multi-pass membrane protein. Cytoplasmic and Nuclear
|
| Specificity |
This is specific for human TERE1.
|
| Clonality |
Polyclonal
|
| Host |
Rabbit
|
| Gene |
UBIAD1
|
| Purity |
Immunogen affinity purified
|
| Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
| Dilutions |
|
| Application Notes |
This antibody is useful for Western blot.
The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
| Theoretical MW |
38 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
Reactivity Notes
Reacts with human. 85% sequence identity with mouse and rat proteins.
Packaging, Storage & Formulations
| Storage |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
|
| Buffer |
PBS
|
| Preservative |
0.02% Sodium Azide
|
| Concentration |
1 mg/ml
|
| Purity |
Immunogen affinity purified
|
Alternate Names for UBIAD1 Antibody
- EC 2.5.1.-
- RP4-796F18.1
- SCCD
- Schnyder crystalline corneal dystrophy
- TERE1transitional epithelia response protein
- Transitional epithelial response protein 1
- UbiA prenyltransferase domain containing 1
- ubiA prenyltransferase domain-containing protein 1
Background
A novel gene designated TERE1, has a significant effect on the growth regulation in bladder cancer. The TERE1 gene maps to a chromosome locus that has been identified by loss of heterozygosity studies as a site of a putative tumor suppressor gene or genes for multiple tumor types including prostate carcinoma. Data suggest that TERE1 may be significant in prostate cancer growth regulation and the down regulation or absence of TERE1 may be an important component of the phenotype of advanced disease. Data also suggest a potential role for this gene product in the progression of bladder cancer.